Simple Blood Test May Detect Down’s Syndrome During Pregnancy
June 30, 2010 by admin · Comments Off
Using existing technology, researchers are hopeful that a simple blood test that can detect fetal DNA in expectant mothers will be able to diagnose Down’s syndrome as early as 8 weeks after conception. Unlike invasive procedures such as amniocentesis and chorionic villus sampling (CVS), the test poses no risk to the fetus.
Caffeine Could Be an Athlete’s New Best Friend
June 30, 2010 by admin · Comments Off
Concentrated doses of caffeine can boost athletic endurance, with certain caveats, and with the removal of caffeine from the list of banned substances, could have an impact in major sporting events. While this news is not necessarily pertinent to the recreational athlete, it does have ramifications for those who partake in competition sports. A high dose of caffeine can increase performance by up to 6 percent, although that is based on activities where muscles are not being worked to the limit.
Sparkle People
June 29, 2010 by admin · Comments Off
SparkPeople, considered by some to be one of the world's leading health and fitness online portals.
Genetic Clue to Infertility Found
June 29, 2010 by admin · Comments Off
Researchers have discovered that some women carry a genetic variation that makes them sub-fertile and less likely to respond to ovarian stimulating hormones during fertility treatment. The discovery opens the way to identifying these women and devising personalized fertility treatments that could bypass the problem caused by the genetic abnormality.
Neurological Stress Reduction Therapy and Shingles
June 29, 2010 by admin · Comments Off
BioVeda Health and Wellness Center of Amarillo, TX recently reports an amazing Neurological Stress Reduction Therapy success story for a patient who was suffering from shingles.
According to Dr. Riemer’s initial patient assessment:
Affected Areas: Right Arm with shingles, C5, 6, and 7 dermatomes involved.
Patient has had BAX procedures 1, 2, 3, 4, and 5 with a few others that were already tested and treated for finishing in January or early February. Patient came in on June 2, 2010 with this shingles condition that she had for approximately 7 days. Patient had visited her MD, and was only prescribed pain relievers – nothing else. Pictures were taken before each BAX Therapy session. Patient was also under the stress of worrying about her husband having early signs of Alzheimer’s.
Results
The following pdf includes before and after photos that show how the patient’s symptoms were alleviated over the course of a 12 Neurological Stress Reduction Therapy sessions. See for yourself these amazing results!
About Shingles (from Wikipedia):
Herpes zoster (or simply zoster), commonly known as shingles and also known as zona, is a viral disease characterized by a painful skin rash with blisters in a limited area on one side of the body, often in a stripe. The initial infection with varicella zoster virus (VZV) causes the acute (short-lived) illness chickenpox which generally occurs in children and young people. Once an episode of chickenpox has resolved, the virus is not eliminated from the body but can go on to cause shingles—an illness with very different symptoms—often many years after the initial infection.
About BAX Neurological Stress ReductionTherapy
The BAX AURA utilizes lasers in a rather unique method that combines the benefits of acupuncture, homeopathy and low level light therapy to increase circulation, reduce inflammation and stimulate cellular growth and repair. This form of laser therapy has proven to modulate the immune response. When coupled with the principles of acupuncture and homeopathy, this form of light therapy grows increasingly effective at increasing lymphatic fluid circulation, boosting the immune system, triggering detoxification and reducing substance specific physiological stress. This combination of wellness techniques can only be accomplished with the BAX AURA System.
Low-level laser therapy (LLLT) has been investigated and used clinically for over 30 years, mostly in Eastern Europe and Asia. Low power or cold lasers can non-thermally and non-destructively alter cellular function. This phenomenon, known as laser biostimulation or photobiomodulation, is the basis for the current use of lasers to treat a variety of articular, neural and soft tissue conditions. This type of therapy has significant published evidence to the efficacy which includes over 200 Randomized Controlled Tests. This evidence is equal or greater than standards for pharmaceutical, surgical and manual therapies for a wide range of pathologies.
Low level light therapy lasers are only capable of delivering a physiological dose of therapy. One of the most important aspects of a physiological dose of therapy is that it is safe. It is safe no matter what the condition or pathology is, no matter what medications the patient is on and no matter what the patient may be allergic to. Due to the low level, non-thermal nature of the laser, there is no tissue destruction or other hazards that you would find associated with the higher powered lasers unless the light is shined directly into the eye. The FDA has classified the most commonly used low level lasers as a class III, non-significant risk, medical devices for investigatory use only. This is the classification of laser incorporated into the BAX AURA system.
